JP2006513238A5 - - Google Patents

Download PDF

Info

Publication number
JP2006513238A5
JP2006513238A5 JP2004565235A JP2004565235A JP2006513238A5 JP 2006513238 A5 JP2006513238 A5 JP 2006513238A5 JP 2004565235 A JP2004565235 A JP 2004565235A JP 2004565235 A JP2004565235 A JP 2004565235A JP 2006513238 A5 JP2006513238 A5 JP 2006513238A5
Authority
JP
Japan
Prior art keywords
iminoethyl
cysteine
ethyl
amino
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004565235A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006513238A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/038792 external-priority patent/WO2004060352A1/en
Publication of JP2006513238A publication Critical patent/JP2006513238A/ja
Publication of JP2006513238A5 publication Critical patent/JP2006513238A5/ja
Pending legal-status Critical Current

Links

JP2004565235A 2002-12-19 2003-12-05 吸湿性薬物を含む非‐吸湿性製剤 Pending JP2006513238A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US43514702P 2002-12-19 2002-12-19
US43502202P 2002-12-19 2002-12-19
US43542202P 2002-12-19 2002-12-19
PCT/US2003/038792 WO2004060352A1 (en) 2002-12-19 2003-12-05 Non-hygroscopic formulation comprising a hydroscopic drug

Publications (2)

Publication Number Publication Date
JP2006513238A JP2006513238A (ja) 2006-04-20
JP2006513238A5 true JP2006513238A5 (https=) 2006-08-10

Family

ID=32719157

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004565235A Pending JP2006513238A (ja) 2002-12-19 2003-12-05 吸湿性薬物を含む非‐吸湿性製剤
JP2004565403A Withdrawn JP2006514052A (ja) 2002-12-19 2003-12-11 吸湿性および／または潮解性の薬剤を含む固体分散剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2004565403A Withdrawn JP2006514052A (ja) 2002-12-19 2003-12-11 吸湿性および／または潮解性の薬剤を含む固体分散剤

Country Status (17)

Country Link
US (2) US20050013856A1 (https=)
EP (2) EP1575563B1 (https=)
JP (2) JP2006513238A (https=)
AR (2) AR042511A1 (https=)
AT (1) ATE353633T1 (https=)
AU (2) AU2003298010A1 (https=)
BR (2) BR0317392A (https=)
CA (2) CA2511385A1 (https=)
DE (1) DE60311875T2 (https=)
ES (1) ES2280835T3 (https=)
HN (1) HN2003000417A (https=)
MX (2) MXPA05006802A (https=)
NL (1) NL1025069C2 (https=)
PE (1) PE20040972A1 (https=)
TW (2) TW200423971A (https=)
UY (1) UY28138A1 (https=)
WO (2) WO2004060352A1 (https=)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1243262T3 (da) 2001-03-20 2006-10-02 Sanol Arznei Schwarz Gmbh Hidtil ukendt anvendelse af en peptidklasse af forbindelser til behandling af ikke-neuropatiske, inflammatoriske smerter
ES2185606T3 (es) 2001-03-21 2003-05-01 Sanol Arznei Schwarz Gmbh Nuevo uso de una clase de compuestos peptidicos para tratamiento de la alodinia u otros tipos diferentes de dolor cronico o fantasma.
SE521512C2 (sv) * 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
EP1575563B1 (en) * 2002-12-19 2007-02-14 Pharmacia Corporation Non-hygroscopic formulation comprising a hydroscopic drug
PT1578422E (pt) * 2002-12-20 2007-06-14 Niconovum Ab Material particulado contendo nicotina fisicamente e quimicamente estável
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
FR2865133B1 (fr) * 2004-01-19 2008-01-18 Rytek Compositions pour le traitement de pathologies digestives
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
KR20070007931A (ko) 2004-04-16 2007-01-16 쉬바르츠파르마에이지 만성 두통의 예방 및 치료를 위한 펩티드 화합물의 용도
WO2006004480A1 (en) * 2004-07-02 2006-01-12 Radi Medical Systems Ab Smokeless toabacco product
PL1781276T3 (pl) * 2004-08-27 2010-11-30 Ucb Pharma Gmbh Zastosowanie związków peptydowych do leczenia bólu związanego z rakiem kości, bólu indukowanego przez chemioterapię oraz nukleozydy
US20060147518A1 (en) * 2004-12-30 2006-07-06 Pierre Fabre Medicament Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it
US20070043120A1 (en) * 2005-08-18 2007-02-22 Bettina Beyreuther Therapeutic combination for painful medical conditions
EP1754476A1 (en) * 2005-08-18 2007-02-21 Schwarz Pharma Ag Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia
US20070048372A1 (en) * 2005-08-18 2007-03-01 Srz Properties, Inc. Method for treating non-inflammatory osteoarthritic pain
WO2007060540A1 (en) * 2005-11-25 2007-05-31 Aurobindo Pharma Limited Stable dosage forms of an antidepressant
AU2007224584A1 (en) 2006-03-16 2007-09-20 Niconovum Ab Improved snuff composition
HRP20110883T1 (hr) * 2006-06-06 2012-01-31 Tibotec Pharmaceuticals Postupak za pripremanje raspršivanjem osušenih formulacija tmc125
WO2007144195A2 (en) 2006-06-15 2007-12-21 Schwarz Pharma Ag Pharmaceutical composition with synergistic anticonvulsant effect
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
BRPI0720472A2 (pt) * 2006-12-22 2014-01-14 Yuhan Corp Dispersão sólida contendo revaprazan e processo para a preparação da mesma
US9358242B2 (en) 2007-08-30 2016-06-07 Prelief Inc. Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
EP2185472A1 (en) * 2007-08-30 2010-05-19 Prelief Inc. Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
KR101499533B1 (ko) 2008-02-15 2015-03-09 주식회사 씨티씨바이오 콜린 알포세레이트 함유 약학 제제
DE102008020701A1 (de) * 2008-04-24 2009-10-29 Bayer Technology Services Gmbh Formulierung mit reduzierter Hygroskopizität
DE102008047910A1 (de) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tablettierhilfsstoff auf Laktose- und Cellulosebasis
KR101172699B1 (ko) 2011-05-16 2012-08-09 한국프라임제약주식회사 콜린알포세레이트를 함유하는 약학 제제, 및 그의 제조방법
US20140130759A1 (en) 2011-07-07 2014-05-15 The Lubrizol Corporation Lubricant Providing Improved Cleanliness For Two-Stroke Cycle Engines
CN102525992A (zh) * 2012-03-09 2012-07-04 徐奎 L-α-甘油磷酸胆碱薄膜衣片及其制备方法
HUE060093T2 (hu) 2012-03-15 2023-01-28 Boehringer Ingelheim Vetmedica Gmbh Gyógyszerészeti tablettakészítmény az állatgyógyászati ágazat számára, eljárás annak elõállítására és annak alkalmazása
US20150141457A1 (en) * 2012-05-21 2015-05-21 Hetero Research Foundation Elvitegravir solid dispersion
HUE054186T2 (hu) 2013-07-19 2021-08-30 Boehringer Ingelheim Vetmedica Gmbh Éterezett ciklodextrin-származékokat tartalmazó, tartósított, folyékony, vizes gyógyászati készítmény
ES2883448T3 (es) * 2013-12-04 2021-12-07 Boehringer Ingelheim Vetmedica Gmbh Composiciones farmacéuticas mejoradas de pimobendán
GB2525170A (en) * 2014-04-07 2015-10-21 Nokia Technologies Oy Stereo viewing
CN104739776A (zh) * 2015-04-15 2015-07-01 福州乾正药业有限公司 左卡尼汀的固体分散体组合物及其制备方法和药物应用
US11154498B2 (en) 2015-07-22 2021-10-26 Leiutis Pharmaceuticals Pvt. Ltd. Stabilized liquid formulation of levothyroxine
BR112018068986B1 (pt) * 2016-03-18 2023-03-21 Christopher Brian Reid Composição para reduzir a expressão oncógena de uma célula, tecido ou órgão de um indivíduo
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
CN111902422A (zh) * 2018-03-30 2020-11-06 株式会社钟化 含有氧化型谷胱甘肽的固体组合物及其制造方法
CN112316678A (zh) * 2020-10-12 2021-02-05 常州市永勃机械有限公司 一种变电站柜体用驱潮剂制备工艺制备方法
IT202100018578A1 (it) * 2021-07-14 2023-01-14 Indena Spa Dispersione amorfa di maltolo ferrico e relativo processo di preparazione

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
JPH02218621A (ja) * 1989-02-20 1990-08-31 Nippon Chemiphar Co Ltd 徐放性製剤
US5582837A (en) * 1992-03-25 1996-12-10 Depomed, Inc. Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
SE9303574D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
WO1995013794A1 (en) * 1993-11-18 1995-05-26 Nippon Shinyaku Co., Ltd. Process for producing stable medicinal composition, and pharmaceutical preparation
JPH08157392A (ja) * 1994-12-01 1996-06-18 Kanegafuchi Chem Ind Co Ltd 放出制御型製剤
GB9607955D0 (en) * 1996-04-17 1996-06-19 Tillotts Pharma Ag Hydrophobic carbomer salt compositions
JPH10182448A (ja) * 1996-12-24 1998-07-07 Zensei Yakuhin Kogyo Kk 圧縮製剤用組成物の製造方法
MA25590A1 (fr) * 1998-09-14 2002-12-31 Inhale Therapeutic Syst Agent actif de delivraison de poudre seche
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
GEP20094625B (en) * 2000-03-24 2009-03-10 Pharmacia Corp Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
US20020143058A1 (en) * 2001-01-24 2002-10-03 Taro Pharmaceutical Inductries Ltd. Process for preparing non-hygroscopic sodium valproate composition
EP1575563B1 (en) * 2002-12-19 2007-02-14 Pharmacia Corporation Non-hygroscopic formulation comprising a hydroscopic drug

Similar Documents

Publication Publication Date Title
JP2006513238A5 (https=)
JP2003213038A5 (https=)
RU2302408C3 (ru) Гидроксаматные производные, применимые в качестве ингибиторов дезацетилазы
JP2007519619A5 (https=)
KR920021578A (ko) 포스프노/비아릴 치환된 디펩티드 유도체
DK1144368T5 (da) Acetyleniske alfa-aminosyrebaserede sulfonamid-hydroxamsyre-TACE-inhibitorer
HRP20140986T1 (hr) Polimorfni oblik derivata 2-amino(nitroaril)tiazola
JP2009501178A5 (https=)
JP2014012726A5 (https=)
JP2007504212A5 (https=)
JPH10152663A5 (https=)
TR200102811T2 (tr) Oral uygulama için, tolpersiyon içeren farmasötik preparat.
JP2002053555A5 (https=)
AR041053A1 (es) Derivados de dioxan-2-alquilcarbamatos, su preparacion y su aplicacion de terapeutica
JP2003510285A5 (https=)
EA200802128A1 (ru) Новые нутрицевтические композиции
JP2010512326A5 (https=)
JP2021123009A5 (https=)
NO20034236L (no) Ny fremgangsmate for den industrielle syntese av tetraestere av 5-[bis(karboksymetyl)amino]-3-karboksymetyl-4-cyano-2-tiofenkarboksylsyre, og anvendelse i syntesen av bivalente salter av ranelinsyre og deres hydrater
JP2008512570A5 (https=)
JP2006348035A5 (https=)
CA2091248A1 (en) Diphenylpiperazine derivative and drug for circulatory organ containing the same
JP2005522492A5 (https=)
JP2007505905A5 (https=)
JP2005524670A5 (https=)